Notably, a recent investigation involving lung cancer patients with TRL who received ICIs revealed that inadequate lymphocyte recovery correlated with a shorter PFS, an increase in regulatory T cells, and a depletion of CD8+ T cells in the peripheral blood. The gene discussed is CD8A; the disease is lung cancer.